Justin Pritchard received his B.S. from U.C.L.A, and his Ph.D. from the labs of Mike Hemann(Cancer Genetics) and Doug Lauffenburger(Biological Engineering). Justin did a postdoc in pathogen genomics in Eric Rubin’s lab at Harvard University where he collaborated heavily with Matthew Waldor’s lab.
WE ARE…THE PRITCHARD LAB
Haider studies approaches that combine drugs to target resistance during therapy. He graduated from the University of Virginia in 2016, where he studied Biomedical Engineering.
Scott is developing innovative ways to combine targeted cancer therapy with gene therapy. He does so by designing genetic constructs that offer control over a tumor’s evolution. Scott uses deterministic and stochastic dynamic modeling to predict the behavior of interacting cell populations and verifies these models in vitro.
Chuan is a medical doctor from Shanghai, China. Chuan’s specialty is oncology. He is interested in combination therapy in Ph+ ALL. Chuan started doing biological research in Professor Hai Jiang’s lab at the Shanghai Institute of Biochemistry and Cell Biology.
Kelly Hartsough is a senior from Boston majoring in biology with the hopes to go on to a PhD program next year. In her graduate studies, she plans to study cellular, molecular, and developmental biology with the goal of a career in industry.